Stocks
GlaxoSmithKline (GSK) Debt US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt, £ | 24 173 000 000 | 20 987 000 000 | 20 987 000 000 | 18 018 000 000 | 18 018 000 000 | 17 772 000 000 | |||
| Changes by years, y/y, % | 0% | -13% | 0% | -14% | 0% | -7.1% | |||
GlaxoSmithKline. Debt, £
GlaxoSmithKline. Debt, changes, %
GlaxoSmithKline (GSK) Debt US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt, £ | 21 474 000 000 | 20 836 000 000 | 18 018 000 000 | 18 018 000 000 | 17 772 000 000 | 17 772 000 000 | ||
| Changes by years, y/y, % | -3% | -6% | -14% | -14% | -15% | |||
| Changes by quarters, q/q, % | 0% | -3% | -14% | 0% | -1% | |||
